Back to search

Boston University

Trends and predictors of women's risk perception about medications that may cause birth defects

Abstract

dc:description.abstract

The purpose of this study was to evaluate the proportion of women who reported perception of medications as a risk for birth defects, whether perceptions have changed over time, and identify socioeconomic and medical factors that are independent predictors of perception of medication risk. The information gained may be useful in developing strategies for the risk management of known teratogens and enhancing the appropriate use of medications known to be safe. From 1976 to 2015, 51,413 women from the Slone Epidemiology Center Birth Defect Study (Slone BDS) were interviewed about whether they were aware of any medication or other substance that might cause birth defects, and about sociodemographic and medical factors. This analysis focused on those participants who reported one or more medication (or vitamin) as a risk factor for birth defects. The results demonstrated a general trend towards fewer women perceiving medication risk over the past four decades. The proportions of women who reported perception were higher for the following variables: older maternal age, white race, higher educational levels, previous pregnancy of a child with reported birth defects, daily medication use during pregnancy, wanted pregnancy, and alcohol use during pregnancy. The study does not support the likelihood of recall bias in women who gave birth to a baby with a birth defect, an important concern in epidemiological studies of birth defects. Misconception of risk was identified; of the top ten medications reported as potentially teratogenic, only three (thalidomide, isotretinoin, and diethylstilbestrol) are established teratogens. Overestimation of risk could potentially impact a woman’s decision to continue a pregnancy or cause unnecessary anxiety when using a medication that is needed during pregnancy. It has previously been shown that counseling pregnant woman can decrease the misperception of teratogenic risk from medications used for nausea and vomiting of pregnancy. Other researchers have suggested that greater use of drug information centers, such as the Norwegian network of drug information centers (RELIS), may help guide pregnant women and prescribing providers to improve teratogenic risk management.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Epidemiology
Grantor
Boston University
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Samuelson, Mark
Advisor dc:contributor.advisor
  • Mitchell, Allen A.

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/34793

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Samuelson, Mark. Trends and predictors of women's risk perception about medications that may cause birth defects. masters thesis, Boston University, 2019. https://hdl.handle.net/2144/34793